The biotech industry includes bio-pharma, bio-services, bio-agri, bio-industrials and bioinformatics. Biopharma is a rapidly growing segment that accounts for a dominant share in this sector. Advancements in biotechnology have enabled researchers to evaluate and identify target biomarkers/cell receptors to develop targeted and personalized therapies. Scientific research and technological advancements have resulted in the emergence of various personalized medicines that are undergoing research. According to research conducted by the Personalized Medicine Coalition, 42% of all compounds and 73% of oncology compounds in the pipeline possess the potential to be personalized medicine. Moreover, according to this study, it is expected that companies will increase their investment in R&D of personalized medicines by 1/3rd over the following five years. The study found that over 20% of drugs approved in 2014 were personalized medicines.

The biotechnology sector has witnessed some disruptive innovations such as gene and cell therapies, immunotherapy, and antibody drug conjugates. Advancement in stem cell therapy is resulting in effective treatment therapies for chronic conditions, organ growth and repair and disease prevention.

Key Challenges

Biotech products have extensive application in oncology and autoimmune disease treatment. However, the cost of these drugs is high owing to extensive research and trials that need to be carried out for the same. Therefore, there is constant pressure to reduce price and increase accessibility, especially in emerging economies. In the U.S., companies are facing reimbursement issues with respect to biopharmaceutical products. Besides, there are regulatory and scientific challenges faced by the sector. Scientific research for new molecules and targeted therapies is capital intensive and challenging owing to growing concern for safety of the drug.

Also, there is lack of awareness about personalized medicine among most healthcare providers, which may hamper its adoption. Clinical adoption of biotechnology products is essential for its success. However, it significant scientific evidence and backing is required to ensure its safety.

“Translating genomic discoveries into personalized medicines entails overcoming substantial scientific, regulatory, and economic challenges, including identifying validated biomarkers, as well as developing personalized therapeutics and clinically relevant diagnostic tests.”

Tufts Center for the Study of Drug Development

Opportunities

The biopharmaceutical sector offers vast lucrative growth opportunities. High efficacy and safety of biopharmaceutical products has led to a growth in their demand, Furthermore, consumers are willing to pay high prices for biopharmaceutical products compared to other conventional products. Biopharmaceutical brands have set new standards for blockbuster drugs by recording an annual average sale of over US$ 2bn. Drugs such as Humira have generated sales revenue of over US$ 10bn.

Governments in emerging economies are endorsing biosimilars as cost-effective alternatives to biotech products, which is expected to create significant growth opportunities for manufacturers of generic drugs. Therefore, cost-effectiveness and high quality are prime parameters that need to be considered while developing biosimilars. Recent and upcoming biologic patent expirations include the following:

Erbitux (cetuximab) - February 2016
Rituxan (rituximab) - September 2016
Herceptin (trastuzumab) - June 2019
Avastin (bevacizumab) - July 2019
Aranesp (darbepoetin alfa) - May 2024
Enbrel (etanercept) - November 2028

Companies such as Teva Pharmaceuticals, Hospira, Sandoz, and Amgen are focusing on development of biosimilars and vaccines as preventive measures in addition to treatment. For instance, in 2015, Zarxio TM became the first biosimilar to be approved in the U.S. market. The EMA approved Mosquirix, a malaria vaccine, in the same year. Extensive research is currently underway to develop a dengue vaccine, which could be another breakthrough pharmaceutical product in the near future.

Conclusion

The increasing research in the biotechnology sector is expected to result in higher number of biopharmaceutical products seeking FDA approvals. Biopharmaceuticals are positioned to be promising treatment solutions that would improve patient outcomes and help with reduction of the cost of drug development.View less

Specialty and Fine Chemicals

Cosmetic Ingredients

Food Ingredients

Aerospace and Defense

Automotive and Transportation

Consumer Electronics

Construction Engineering

Industrial Automation and Machinery

Semiconductors

Smart Technologies

Information and Communication Technology

Biotechnology Published Insights

Pneumococcal Vaccines Market

Published Date : Feb 2025

Global pneumococcal vaccines market growth is driven by factors such as rising incidence of pneumococcal diseases worldwide and growing immunization programs by various governments. Moreover, increasing awareness among people regarding pneumococcal vaccina... View more

Recombinant Dna Technology Market

Published Date : Feb 2025

Global recombinant DNA technology market is estimated to be valued at USD 189.91 Bn in 2025 and is expected to exhibit a CAGR of 9.8% during the forecast period (2025-2032). Recombinant DNA technology is the joining together of DNA molecules from two different sourc... View more

Platelet Rich Plasma Market

Published Date : Feb 2025

The global platelet rich plasma market is estimated to be valued at USD 620.5 Mn in 2025 and is expected to exhibit a CAGR of 12.7% during the forecast period (2025-2032). Platelet Rich Plasma (PRP) is an enriched concentration of platelets extracted from a small vo... View more

Pharmacogenomics Market

Published Date : Feb 2025

The global pharmacogenomics market is estimated to be valued at USD 19.24 Bn in 2025 and is expected to exhibit a CAGR of 11.9% during the forecast period (2025-2032). Pharmacogenomics is the branch of science that analyzes how genes affect a person's response to me... View more

Biochips Market

Published Date : Feb 2025

Global biochips market consists of technology used for detecting and identifying biological molecules from pathogens and genes to proteins and DNA sequences. Biochips are used in drug discovery, disease diagnosis, and food safety, among others. Increasing ... View more

Flow Cytometry Market

Published Date : Feb 2025

Global flow cytometry market is estimated to be valued at USD 8.35 Bn in 2025 and is expected to exhibit a CAGR of 11.0% during the forecast period (2025-2032). The global flow cytometry market has been witnessing steady growth over the past few years due to the inc... View more

Anti Venom Market

Published Date : Feb 2025

Global anti venom market growth is driven by rising incidence of snake bites and scorpion stings across tropical and sub-tropical regions of the world. Each year over 5 million people are bitten by snakes, out of which, around 2.7 million cases result in envenoming an... View more

Genome Engineering Market

Published Date : Feb 2025

Global genome engineering market is estimated to be valued at USD 7.70 Bn in 2025, and is expected to exhibit a CAGR of 14.7% during the forecast period (2025-2032). Genome engineering, also known as genetic engineering, is a set of technologies that enable genetic ... View more

Synthetic Biology Market

Published Date : Feb 2025

The global synthetic biology market is estimated to be valued at USD 21.90 Bn in 2025 and is expected to exhibit a CAGR of 22.5% during the forecast period (2025-2032). Synthetic biology is an emerging field that applies engineering principles to biology. It involve... View more

Cell Culture Market

Published Date : Feb 2025

The global cell culture market is estimated to be valued at USD 25.27 Bn in 2025 and is expected to exhibit a CAGR of 12.0% during the forecast period (2025-2032). The cell culture market has seen significant growth in the last few decades driven by advancements in bi... View more

Digital Genome Market

Published Date : Feb 2025

The global digital genome market is set to grow substantially over the next decade driven by declining costs of genomic sequencing and data analysis. Advancements in technologies for high-throughput DNA sequencing are enabling researchers to sequence entire human geno... View more

Next Generation Sequencing Market

Published Date : Feb 2025

Global next generation sequencing market is estimated to be valued at USD 18.94 Bn in 2025 and is expected to exhibit a CAGR of 14.7% during the forecast period (2025-2032). Next Generation Sequencing (NGS) refers to the high-throughput DNA sequencing technologies t... View more

Personalized Cell Therapy Market

Published Date : Feb 2025

Global personalized cell therapy market growth is driven by increasing R&D investments by key players in developing advanced cell therapies for treating various chronic and life-threatening diseases. Personalized cell therapy involves isolation and manipulation of... View more

Bone Marrow Transplant Market

Published Date : Feb 2025

Bone marrow transplant is a procedure that infuses healthy bone marrow stem cells to replace the damaged or unhealthy bone marrow of a patient. It is commonly used for treating various blood cancers like leukemia, lymphoma and other blood disorders. The stem cells can... View more

Immunotherapy Drugs Market

Published Date : Feb 2025

Global immunotherapy drugs market is estimated to be valued at USD 185.72 Bn in 2025 and is expected to exhibit a CAGR of 11.5% during the forecast period (2025-2032). Immunotherapy drugs utilize the body's immune system to fight cancer and other diseases. These dru... View more

Biosimilars Market

Published Date : Feb 2025

Global biosimilars market growth is driven by rising healthcare costs worldwide and the expiration of blockbuster biologics patents. Biosimilars provide affordable treatment options for chronic diseases such as cancer, diabetes, and autoimmune disorders. These offer s... View more

Aptamers Market

Published Date : Feb 2025

Global aptamers market is estimated to be valued at USD 8.60 Bn in 2025 and is expected to exhibit a CAGR of 18.0% during the forecast period (2025-2032). Aptamers are single stranded Deoxyribonucleic acid (DNA) or Ribonucleic acid (RNA) molecules that bind to a spe... View more

Personalized Medicine Biomarkers Market

Published Date : Feb 2025

Global personalized medicine biomarkers market is estimated to be valued at USD 28.61 Bn in 2025 and is expected to reach USD 79.92 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 15.8% from 2025 to 2032. Personalized medicine biomarkers market refe... View more